Business Context and Reporting Period
This Form 8-K was filed by Conversion Labs, Inc. on August 7, 2020. The report details the termination of a strategic partnership and the dissolution of a subsidiary, Conversion Labs RX, LLC ("CLRX"), which was formed in 2019 to operate an online pharmacy and telemedicine business.
Key Financial Metrics
The filing does not provide specific financial statements, revenue figures, profit margins, cash flow data, debt levels, or liquidity metrics. The document explicitly states that CLRX never commenced operations and held no assets as of the effective date.
Material Changes
- Dissolution of Subsidiary: Conversion Labs RX, LLC (CLRX) was dissolved effective August 7, 2020, following the filing of a Certificate of Dissolution with the Puerto Rico Secretary of State.
- Termination of Strategic Partnership: The non-exclusive Strategic Partnership Agreement with Specialty Drugstore Inc. (d/b/a GoGoMeds) was terminated as it is no longer considered material.
- Termination of Consulting Agreement: The consulting agreement with Harborside Advisors, LLC was terminated. No services were rendered, and no consideration was paid under this agreement.
- Operational Shift: The Company's online pharmacy and telemedicine business is now conducted solely through its wholly owned operating subsidiary, Conversion Labs PR, LLC.
Outlook, Risks, and Management Commentary
Management indicates that the CLRX entity was inactive since its inception. The dissolution and agreement terminations were executed to streamline operations, with the business continuing through Conversion Labs PR, LLC. No specific forward-looking guidance, risk factors, or unusual items regarding future financial performance are disclosed in this specific filing.
Key Facts for Investor Verification
- Verify that the Company's telemedicine and pharmacy operations are fully integrated into Conversion Labs PR, LLC.
- Confirm that no liabilities or contingent obligations remain from the dissolved CLRX entity or the terminated GoGoMeds partnership.
- Ensure that no payments were made to Harborside Advisors, LLC under the terminated consulting agreement.
- Review subsequent filings for updated financial performance of the consolidated entity now operating through Conversion Labs PR, LLC.